Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer-Reference-Cited by-同舟云学术

Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer

Published:2012-07-06 Issue:2 Volume:20 Page:197-205
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:Journal of Hepato-Biliary-Pancreatic Sciences

Author:

Sho Masayuki¹,Akahori Takahiro¹,Tanaka Toshihiro²,Kinoshita Shoichi¹,Tamamoto Tetsuro³,Nomi Takeo¹,Yamato Ichiro¹,Hokuto Daisuke¹,Yasuda Satoshi¹,Kawaguchi Chihiro¹,Nishiofuku Hideyuki²,Marugami Nagaaki²,Enomonoto Yasunori⁴,Kasai Takahiko⁴,Hasegawa Masatoshi³,Kichikawa Kimihiko²,Nakajima Yoshiyuki¹

Affiliation:

1. Department of Surgery; Nara Medical University; 840 Shijo-cho Kashihara Nara 634-8522 Japan

2. Department of Radiology; Nara Medical University; Kashihara Nara 634-8522 Japan

3. Department of Radiation Oncology; Nara Medical University; Kashihara Nara 634-8522 Japan

4. Department of Diagnostic Pathology; Nara Medical University; Kashihara Nara 634-8522 Japan

Publisher

Wiley

Subject

Hepatology,Surgery

Reference37 articles.

1. Pancreatic cancer: surgery alone is not sufficient;Traverso;Surg Endosc.,2006

2. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?;Schnelldorfer;Ann Surg.,2008

3. Pancreatic adenocarcinoma: the actual 5-year survivors;Ferrone;J Gastrointest Surg.,2008

4. Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial;Oettle;JAMA,2007

5. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer;Ueno;Br J cancer,2009

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of carbonic anhydrase 9 expression on neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma;Pancreatology;2024-09

2. Impact of pancreatic ductal occlusion on postoperative outcomes in pancreatic head cancer patients undergoing neoadjuvant therapy;Journal of Gastroenterology;2024-06-20

3. Combination of carbohydrate antigen 19-9 level and tumor size after neoadjuvant chemoradiation therapy may predict early recurrence of resectable pancreatic ductal adenocarcinoma;Pancreatology;2023-12

4. Central pancreatectomy might be an acceptable surgical procedure for clinical T1 pancreatic body ductal adenocarcinoma: A multicenter retrospective analysis;Journal of Hepato-Biliary-Pancreatic Sciences;2023-10-04

5. Significance of multiple tumor markers measurements in conversion surgery for unresectable locally advanced pancreatic cancer;Pancreatology;2023-09